127 related articles for article (PubMed ID: 8386825)
1. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor.
Galland F; Karamysheva A; Pebusque MJ; Borg JP; Rottapel R; Dubreuil P; Rosnet O; Birnbaum D
Oncogene; 1993 May; 8(5):1233-40. PubMed ID: 8386825
[TBL] [Abstract][Full Text] [Related]
2. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines.
Pajusola K; Aprelikova O; Korhonen J; Kaipainen A; Pertovaara L; Alitalo R; Alitalo K
Cancer Res; 1992 Oct; 52(20):5738-43. PubMed ID: 1327515
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase.
Borg JP; deLapeyrière O; Noguchi T; Rottapel R; Dubreuil P; Birnbaum D
Oncogene; 1995 Mar; 10(5):973-84. PubMed ID: 7898938
[TBL] [Abstract][Full Text] [Related]
4. Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family.
Rosnet O; Marchetto S; deLapeyriere O; Birnbaum D
Oncogene; 1991 Sep; 6(9):1641-50. PubMed ID: 1656368
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
[TBL] [Abstract][Full Text] [Related]
6. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
[TBL] [Abstract][Full Text] [Related]
7. Characterization of murine Flt4 ligand/VEGF-C.
Fitz LJ; Morris JC; Towler P; Long A; Burgess P; Greco R; Wang J; Gassaway R; Nickbarg E; Kovacic S; Ciarletta A; Giannotti J; Finnerty H; Zollner R; Beier DR; Leak LV; Turner KJ; Wood CR
Oncogene; 1997 Jul; 15(5):613-8. PubMed ID: 9247316
[TBL] [Abstract][Full Text] [Related]
8. Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts.
Pajusola K; Aprelikova O; Armstrong E; Morris S; Alitalo K
Oncogene; 1993 Nov; 8(11):2931-7. PubMed ID: 7692369
[TBL] [Abstract][Full Text] [Related]
9. FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter.
Aprelikova O; Pajusola K; Partanen J; Armstrong E; Alitalo R; Bailey SK; McMahon J; Wasmuth J; Huebner K; Alitalo K
Cancer Res; 1992 Feb; 52(3):746-8. PubMed ID: 1310071
[TBL] [Abstract][Full Text] [Related]
10. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.
Shibuya M; Yamaguchi S; Yamane A; Ikeda T; Tojo A; Matsushime H; Sato M
Oncogene; 1990 Apr; 5(4):519-24. PubMed ID: 2158038
[TBL] [Abstract][Full Text] [Related]
11. The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors.
Dumont DJ; Gradwohl GJ; Fong GH; Auerbach R; Breitman ML
Oncogene; 1993 May; 8(5):1293-301. PubMed ID: 8386827
[TBL] [Abstract][Full Text] [Related]
12. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of murine FLT and FLT4.
Finnerty H; Kelleher K; Morris GE; Bean K; Merberg DM; Kriz R; Morris JC; Sookdeo H; Turner KJ; Wood CR
Oncogene; 1993 Aug; 8(8):2293-8. PubMed ID: 8393164
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.
Lee J; Gray A; Yuan J; Luoh SM; Avraham H; Wood WI
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1988-92. PubMed ID: 8700872
[TBL] [Abstract][Full Text] [Related]
15. Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor.
Fournier E; Dubreuil P; Birnbaum D; Borg JP
Oncogene; 1995 Sep; 11(5):921-31. PubMed ID: 7675451
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant.
Whittle C; Gillespie K; Harrison R; Mathieson PW; Harper SJ
Clin Sci (Lond); 1999 Sep; 97(3):303-12. PubMed ID: 10464055
[TBL] [Abstract][Full Text] [Related]
17. Close physical linkage of the FLT1 and FLT3 genes on chromosome 13 in man and chromosome 5 in mouse.
Rosnet O; Stephenson D; Mattei MG; Marchetto S; Shibuya M; Chapman VM; Birnbaum D
Oncogene; 1993 Jan; 8(1):173-9. PubMed ID: 8380915
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor: possible role in fetal development and placental function.
Cheung CY
J Soc Gynecol Investig; 1997; 4(4):169-77. PubMed ID: 9292845
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta.
Ziegler SF; Bird TA; Schneringer JA; Schooley KA; Baum PR
Oncogene; 1993 Mar; 8(3):663-70. PubMed ID: 8382358
[TBL] [Abstract][Full Text] [Related]
20. Genomic organization of the human c-kit gene: evolution of the receptor tyrosine kinase subclass III.
André C; Martin E; Cornu F; Hu WX; Wang XP; Galibert F
Oncogene; 1992 Apr; 7(4):685-91. PubMed ID: 1373482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
